The adverse effects of preoperative cholangitis on the outcome of portal vein embolization and subsequent major hepatectomies
Executive Summary
This briefing document analyzes the clinical consequences of preoperative cholangitis in patients undergoing portal vein embolization (PVE) and subsequent major hepatectomy. Based on a retrospective study of 450 patients, the presence of cholangitis significantly compromises the efficiency of liver regeneration and worsens postoperative outcomes.
Critical findings include:
Delayed Regeneration: Patients with cholangitis require a significantly longer waiting period (24.3 days vs. 18.3 days) to meet institutional safety criteria for surgery after PVE, due to a lower daily liver volume increase rate.
Increased Morbidity: Preoperative cholangitis is an independent risk factor for postoperative morbidity, with an odds ratio of 2.83. The morbidity rate in the cholangitis group was 78% compared to 56% in the noncholangitis group.
Postoperative Complications: These patients face higher rates of posthepatectomy liver failure, higher maximum serum total bilirubin levels, and a higher incidence of infectious complications, leading to prolonged hospital stays.
Study Overview and Methodology
The primary objective of the research was to determine if preoperative cholangitis impacts hepatic regeneration after PVE and the subsequent postoperative course in humans. While experimental rat models had previously suggested that segmental cholangitis suppresses liver regeneration, this study provides the first comprehensive clinical analysis in humans.
Patient Population and Criteria
Cohort: 450 patients treated between May 1991 and February 2012 at Nagoya University Hospital.
Cholangitis Group: 72 patients (16.0%) who met specific criteria: sustained fever requiring antibiotics, increased hepatobiliary enzymes, and bacteria isolation from bile cultures.
Noncholangitis Group: 378 patients (84.0%).
Surgical Scope: Major hepatectomy, defined as the resection of four or more Couinaud segments.
Clinical Protocols
Safety Criteria: Surgery was generally performed only when the future liver remnant plasma disappearance rate of indocyanine green (ICGK-F) reached ≥ 0.05.
PVE Procedure: Performed to increase future liver remnant (FLR) volume when the liver parenchyma resection rate exceeded 60% or functional reserves were insufficient.
Management: PVE or surgery was postponed for at least 1–2 weeks until cholangitis symptoms subsided.
Impact on Preoperative Liver Regeneration
The study found that while the ultimate volume of the nonembolized lobe increased in both groups, the rate and timing of this growth were adversely affected by cholangitis.
Key Insight: Patients with cholangitis did not reach the functional threshold (ICGK-F \ge 0.05) within the standard 20-day window, necessitating extended waiting periods before they could safely undergo major surgery.
Postoperative Outcomes and Complications
Preoperative cholangitis correlates with a more difficult and dangerous postoperative recovery. The study observed significant differences in several key clinical metrics.
Surgical Complexity
Patients with preoperative cholangitis often required more complex intraoperative procedures:
Portal Vein Resection: 53% in the cholangitis group vs. 36% in the noncholangitis group (P = .006).
Operation Time: Mean of 694 minutes vs. 644 minutes (P = .013).
Blood Loss: Significantly higher in the cholangitis group (mean 2,781 mL vs. 2,264 mL).
Recovery and Morbidity
The postoperative course for cholangitis patients was marked by higher rates of organ dysfunction and infection.
Risk Factor Analysis
Multivariate logistic regression was used to isolate the factors most responsible for postoperative morbidity. Preoperative cholangitis was identified as one of the most potent independent risk factors.
Independent Risk Factors for Morbidity:
Preoperative Cholangitis: Odds Ratio (OR) 2.83 (P = .001).
Operation Time (> 10 hours): OR 4.15 (P < .001).
Combined Pancreatoduodenectomy: OR 1.88 (P = .030).
Notably, age, sex, and preoperative bilirubin levels (when treated prior to surgery) were not identified as independent risk factors in the multivariate analysis.
Clinical Discussion and Conclusions
Pathophysiological Mechanisms
The study suggests two primary reasons for the unfavorable outcomes in cholangitis patients:
Suppressed Regeneration: Consistent with rat models, cholangitis appears to alter the expression of regeneration-promoting and inhibiting factors, though the exact mechanism remains unknown.
Biliary Contamination: Because most patients (98%) underwent extrahepatic bile duct resection and hepaticojejunostomies, the risk of surgical field contamination by infected bile was high. Microorganisms isolated from postoperative infection sites often matched those found in preoperative bile cultures.
Recommendations
Perioperative Management: Patients with a history of cholangitis require more intensive monitoring and careful management during the waiting period after PVE and following major hepatectomy.
Biliary Drainage: Preoperative biliary drainage is essential, and additional drainage should be considered if segmental cholangitis is suspected in undrained branches.
Antibiotic Prophylaxis: Preoperative surveillance of bile cultures is helpful in selecting appropriate prophylactic antibiotics to mitigate the high risk of infectious complications.
The researchers conclude that preoperative cholangitis is a major negative prognostic factor, impairing both the liver's ability to regenerate after PVE and the patient's ability to recover from major hepatic resection.
